Mine & Arao Wealth Creation & Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Mine & Arao Wealth Creation & Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12	Closed	-$1.76K	–	333
2023 Q1	$1.76K	Hold	12	–	–	﹤0.01%	304
2022 Q4	$1.91K	Hold	12	–	–	﹤0.01%	297
2022 Q3	$2K	Hold	12	–	–	﹤0.01%	312
2022 Q2	$2K	Hold	12	–	–	﹤0.01%	304
2022 Q1	$2K	Hold	12	–	–	﹤0.01%	301
2021 Q4	$2K	Hold	12	–	–	﹤0.01%	304
2021 Q3	$2K	Hold	12	–	–	﹤0.01%	275
2021 Q2	$2K	Buy	+12	New	+$2.08K	﹤0.01%	270

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Mine & Arao Wealth Creation & Management's JAZZ Position: Q2 2023 in Review

Mine & Arao Wealth Creation & Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2023, closing a stake of 12 shares — an estimated $1.76K sold.

Mine & Arao Wealth Creation & Management first reported a position in JAZZ in Q2 2021 and held it in 8 quarters. The position peaked at $2K in Q3 2022. 471 funds tracked by Wall St. Rank hold JAZZ as of Q2 2023.

Mine & Arao Wealth Creation & Management reported no remaining Jazz Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Mine & Arao Wealth Creation & Management sold 12 Jazz Pharmaceuticals shares in Q2 2023, an estimated $1.76K.
Mine & Arao Wealth Creation & Management first reported a position in Jazz Pharmaceuticals in Q2 2021 and held it in 8 quarters.
Mine & Arao Wealth Creation & Management's Jazz Pharmaceuticals position peaked at $2K in Q3 2022.
471 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2023.

Based on Mine & Arao Wealth Creation & Management's 13F filing for Q2 2023, filed 8 Aug 2023.